SBIR/STTR Research Award

A biodegradable barrier preventing anastomotic leaks after esophagectomy

Award identifier 93e7f390c18f235a58d1477ff5023ddbaf99bc55a1d14ae0c56bd1de6f50e2f6Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$406,500

Program and phase

SBIR · Phase I

Award year

2025

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
SAFEGUARD SURGICAL LLC
Proposal award date
2025-09-18
Contract end date
2026-08-31
UEI
GCANPGXV3X55
Solicitation number
PA24-245
Topic code
102

Research abstract

Project Summary/Abstract This SBIR Phase I application will demonstrate feasibility of LeakGuard by: 1) assessing the mechanical and degradation properties of LeakGuard in esophageal-like conditions and 2) demonstrating LeakGuard’s ability to protect from anastomotic leakage after esophageal resection in the porcine model. Esophageal cancer affects over 50,000 Americans each year. The gold-standard treatment is esophageal resection, but up to 22% of patients develop a complication called anastomotic leakage (AL), resulting in high morbidity and mortality. Current treatments, such as stents and endoscopic vacuum therapy, do not prevent AL and still often result in high patient morbidity and mortality, as well as extended time spent in the hospital. Existing preventative solutions, such as omentoplasty, are surgical based and cannot be performed on every patient and have the potential to result in very serious complications. Therefore, an unmet need exists for an effective method to prevent AL that can be used on any patient, reducing the morbidity and mortality of esophagectomy. SafeGuard Surgical has developed LeakGuard, a biodegradable barrier device that is prophylactically placed within the esophageal lumen during esophagectomy. It covers and protects the esophagogastric anastomotic site enabling esophageal healing, while concurrently preventing anastomotic leakage. The biodegradability of LeakGuard allows for it to be administered during the esophagectomy, eliminating the need for a second surgery. To determine the feasibility of the device, the mechanical and degradation proprieties of LeakGuard will be assessed at pH within the esophageal lumen (4.0 and 7.0). The tensile strength, burst pressure, and fluid permeability will be determined. The ability of the LeakGuard to protect from AL in vivo will be evaluated in a pig model. Pigs will undergo an esophagectomy, and a simulated leak will be created and LeakGuard administered. Pigs will be sacrificed at 7 days, 14 days, and 28 days to evaluate healing and the degree of leak protection. Successful completion of this project will validate that LeakGuard can be used to protect from anastomotic leakage post-esophagectomy.

Technology keywords

Not reported

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.